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FusionQ: a novel approach for gene fusion
detection and quantification from paired-end
RNA-Seq
Chenglin Liu1,2, Jinwen Ma2, ChungChe (Jeff) Chang3 and Xiaobo Zhou1*
Abstract
Background: Gene fusions, which result from abnormal chromosome rearrangements, are a pathogenic factor in
cancer development. The emerging RNA-Seq technology enables us to detect gene fusions and profile their
features.
Results: In this paper, we proposed a novel fusion detection tool, FusionQ, based on paired-end RNA-Seq data. This
tool can detect gene fusions, construct the structures of chimerical transcripts, and estimate their abundances. To
confirm the read alignment on both sides of a fusion point, we employed a new approach, “residual sequence
extension”, which extended the short segments of the reads by aggregating their overlapping reads. We also
proposed a list of filters to control the false-positive rate. In addition, we estimated fusion abundance using the
Expectation-Maximization algorithm with sparse optimization, and further adopted it to improve the detection
accuracy of the fusion transcripts. Simulation was performed by FusionQ and another two stated-of-art fusion
detection tools. FusionQ exceeded the other two in both sensitivity and specificity, especially in low coverage
fusion detection. Using paired-end RNA-Seq data from breast cancer cell lines, FusionQ detected both the
previously reported and new fusions. FusionQ reported the structures of these fusions and provided their
expressions. Some highly expressed fusion genes detected by FusionQ are important biomarkers in breast cancer.
The performances of FusionQ on cancel line data still showed better specificity and sensitivity in the comparison
with another two tools.
Conclusions: FusionQ is a novel tool for fusion detection and quantification based on RNA-Seq data. It has both
good specificity and sensitivity performance. FusionQ is free and available at http://www.wakehealth.edu/CTSB/
Software/Software.htm.
Keywords: Fusion detection, chimerical transcripts quantification, EM algorithm
Background
Cancer is fundamentally the result of a wide range of gen-
omic alterations. Abnormal chromosome rearrangement is
one of its key features and highly involved in hematopoietic
diseases. The chromosome breakage and rejoining result in
gene fusions, which hybridize the previously separated
genes. An increasing number of gene fusions are being
considered as important parameters in the diagnosis and
prognosis of malignant hematological disorders [1]. A well-
known prototype example is the BCR-ABL1 fusion gene,
which has been confirmed as a key pathogenic factor for
chronic myeloid leukemia [1]. Recent studies suggest that
causal gene fusions may also exist in epithelial-origin car-
cinomas, and specify the TMPRSS2-ERG gene fusion in
prostate cancers [2], and BCAS4-BCAS3 gene fusion in
breast cancers [3] as examples. Analysis of these gene fu-
sions from a perspective of genome sequence and structure
could provide relevant data that could guide development
of improved cancer diagnostics and targeted therapies.
Advances in next-generation sequencing (NGS) technol-
ogy have imparted a new approach to systematically identify
genomic alterations. The sequencing instruments provide a
set of deep coverage and base level sequence data, giving a
new picture of genes expressed in a cell. Application of one
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of the NGS approaches, whole transcriptome sequencing
(RNA-Seq) technology, allows for the study of functional
fusion genes, and gene structures and expressions. Com-
pared to whole-genome sequencing, RNA-Seq focuses on
expressed gene fusions, which are very important in cancer
development [4]. RNA-Seq technology has been shown to
be a powerful tool for gene fusion detection.
Recent gene fusion studies have developed several tools
for gene fusion detection. FusionSeq [5] identifies gene fu-
sions from discordant alignments, introducing numerous
filters to separate the real fusions from many false-positive
ones. However, this method can only detect the fusions
between annotated genes, and may miss some fusions due
to the incomplete annotation of a complex transcriptome.
In addition, it is quite time and space consuming com-
pared to other tools. The deFuse [6] uses dynamic pro-
gramming to distinguish spanning pairs by split read
analysis. However, it operates under the restriction that
there are at least five spanning pairs; hence, it is very in-
sensitive to fusions from RNA-Seq datasets with minimal
sequence generation. Meanwhile, the classifier to distin-
guish the true fusions from the false positives is highly re-
lated to a fixed training set generated from cell lines. The
training set may not be applicable to other cell lines or
clinical sample datasets. Fusion-Hunter [7] and TopHat-
Fusion [8] use a splice algorithm for gene fusion detection.
For splice algorithm, the problem occurs when confirming
the alignments of the short sequences around the fusion
point [9]. Fusion-Hunter simply aligns the short segments,
which will introduce many false positives. TopHat-Fusion
searches and merges reads together, but operates under
the restriction that there should be 13bp on both sides of
fusion points. In addition, all of the aforementioned ap-
proaches use the numbers of fusion reads to quantifying
the fusion expression levels, which only represent the
abundances of small regions around the fusion points.
In this article, we proposed a new tool, FusionQ, which
can detect gene fusions, construct the chimerical tran-
script structures, and estimate their expressions. FusionQ
uses a splice algorithm for fusion detection. A new ap-
proach, “residual sequence extension”, is proposed in
FusionQ to overcome the problem of multiple alignments
of short sequences that is commonly seen in splice algo-
rithms. Based on this method, longer sequences can be
obtained around the fusion point to confirm their align-
ments in FusionQ. To reduce the false-positive rate,
FusionQ introduces a list of filters, including read number,
sequence similarity, read position distribution filter. These
filters guarantee FusionQ to obtain results with high speci-
ficity. In addition, FusionQ uses a more stable method to
quantify fusion expressions. It incorporates the platform
of expression estimation tool RSEM (RNA-Seq by Expect-
ation Maximization) [10,11], and uses the Expectation
Maximization (EM) algorithm with sparse optimization to
estimate chimerical transcript abundance. Furthermore,
this abundance quantification can be increase the identifi-
cation accuracy of FusionQ. Taken together, these features
allow FusionQ to provide a more complete view of gene
fusion events.
Methods
In this study, we generated 50 datasets of simulated
paired-end RNA-Seq reads using “Eric the simulator”
[12]. Each dataset contained 50 simulated gene fusions,
with the coverage from 1 to 50. The simulation steps
are summarized in the Result Section: comparison on
simulated data. Furthermore, we analyzed a published
paired-end RNA-Seq dataset (from NCBI Sequence
Read Archive [SRA: SRP003186, http://trace.ddbj.nig.
ac.jp/DRASearch/study?acc=SRP003186]). It includes
data from four breast cancer cell lines (BT474, SKBR3,
KPL4, and MCF7), which are known to contain 27 gene
fusions. Additionally, we employed a control group
from this dataset, which is the RNA-Seq data from nor-
mal tissue.
In order to describe FusionQ clearly, some concepts must
first be clarified. According to paired-end RNA-Seq tech-
nology, a library of cDNA fragments is derived from long
RNAs by RNA or DNA segmentation. Short sequences
from these paired-ends can be obtained after attaching
adaptors to both ends of cDNA fragments. These se-
quences are termed paired-end reads. Due to the limitation
of sequencing length, the middle portion of the cDNA frag-
ments may not be sequenced. These non-sequenced seg-
ments are called insert sequences. If a fusion point, which
is the joint point of two fused genes, is located in a cDNA
fragment, it should exist in either one of the paired-end
reads or the insert sequence. A read satisfying the former
case is termed a split read, while paired-end reads satisfying
the latter case are termed spanning pairs. As to a split read,
if the segment on each side of its fusion point can align to a
unique gene, the fusion reads are termed as uniquely
mapped reads. We graphically describe these two types of
fusion reads in Figure 1.
The fusion detection process of FusionQ is schematic-
ally described in Figure 2.
As seen in Figure 2, FusionQ is composed of three
phases:
Phase I Transcriptome construction from RNA-Seq;
Phase II Fusion reads detection based on the
constructed transcriptome;
Phase III Chimerical transcript quantification.
The transcript library constructed in phase I contains
both known and new transcripts. FusionQ then aligns reads
to this constructed transcriptome. As a result, it can detect
both known and novel gene fusions. In phase II, FusionQ
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detects the spanning reads by finding the paired-end reads
with discordant alignments, with two ends aligned to differ-
ent genes, while it detects the split reads by determining if
the reads that cannot be aligned to the transcriptome har-
bor fusion points or not. A residual sequence extension
method is proposed in this step, which can largely decrease
the false-positive rate in fusion detection. The last phase,
quantification of chimerical transcripts, is fulfilled using the
Expectation Maximization (EM) algorithm with sparse
optimization. A detailed explanation of these phases is as
follows:
Phase I. Transcriptome construction from RNA-Seq
One advantage of RNA-Seq technology is that it can
identify transcript structures without knowledge from
a pre-existing gene library, and is able to detect novel
genes or isoforms. Gene fusion detection from RNA-
Seq data should also include the detection of these novel
gene fusions to avoid missing fusions due to the incom-
plete annotation of a complex transcriptome. To address
this problem, FusionQ directly constructs the transcrip-
tome from the RNA-Seq data using the transcriptome
construction tool, Cufflinks [13]. In addition, a reference
annotation to guide the assembly steps is supplied. The
output transcriptome by Cufflinks includes all reference
transcripts, as well as the novel isoforms. Hence, this ap-
proach can report gene fusions between annotated genes
and novel genes. Supplying the reference annotation as-
sists in ensuring that low expressed transcripts are not
missed and that the constructed transcriptome is more
complete. FusionQ then creates a Bowtie index of the
transcriptome using the Bowtie-build program [14].
Figure 1 A spanning pair is 1 paired-end read with discordant alignments. A split read is a read that contains the fusion point, with the
segments separated by the fusion point mapped to different genes. The green and red long rectangles represent the reference sequences of
gene1 and gene2, while the green and red arrows represent reads or segments mapped to gene1 and gene2, respectively.
Figure 2 Flowchart of FusionQ. FusionQ constructs the reference transcriptome directly from the RNA-Seq data, and detects the two
types of fusion reads based on it. The proposed residual sequence extension method makes the short residual sequence longer, and therefore
has a higher probability for unique mapping and increases the specificity of the detection results. The chimerical transcript quantification is based
on the RSEM algorithm.
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Phase II. Fusion reads detection based on the constructed
transcriptome
1. Mapping
Based on the created index from phase I, FusionQ
first uses Bowtie to map all reads to the constructed
transcriptome. The paired-end reads with
concordant alignments and reasonable insertion
lengths are filtered out from the consideration of
fusion reads. The paired-end reads with discordant
alignments are considered as spanning reads. Some
paired-end reads having neither ends aligned to the
transcriptome are split into halves. If each end of
one paired-end read has half mapped to the
transcriptome, and the alignments are discordant,
these paired-end reads are still considered as
spanning reads. If one paired-end read has one end
mapped to the transcriptome while the other not,
the non-mapped end may harbour a fusion point.
This type of non-mapped read is selected as a
candidate split read. This mapping step allows a
number of mismatches according to the
transcriptome, considering sequencing errors and
single nucleotide polymorphisms.
2. Splitting reads into halves
The candidate split reads are split in the middle. For
the purposes of this study, it was assumed that a
split read harbors only one fusion point. If this read
is then split in the middle, at least half can align to
the transcriptome. This half read is called a seed. To
guarantee that most half reads do not have too many
mapping positions, read lengths are restricted to be
more than 50bp, because 25bp reads have a high
probability to align to unique genes of the
constructed transcriptome. This conclusion is based
on the following example. Ten thousand (10000)
25bp reads that can align to a constructed
transcriptome were chosen at random. Almost 75%
of them could align uniquely, with only less than 5%
of the reads mapped to more than three genes.
Therefore, the detected seeds are restricted so as to
have no more than one mismatch based on the
transcriptome.
3. Fusion breakpoint detection
In the following extension step, the detected seeds
are extended, nucleotide by nucleotide. Extension is
stopped when further extension results in no
mapping position. This stop point is regarded as the
fusion breakpoint. The remaining segment that does
not undergo seed extension is called a residual
sequence. The implying genes of the seed and
residual sequence are the gene fusion partners.
Clearly, the length of the residual sequences is less
than half of the read length. Consequently, it cannot
be guaranteed that most of them align to less than
three genes. Some split reads may be missed by
simply disregarding some of the short residual
sequences. However, if those residual sequences have
too many mapping positions, the false-positive rate
may increase. Consequently, while considering both
detection sensitivity and specificity, the problem of
how best to determine implying genes from the
residual sequences presents. Residual sequence
extension is therefore proposed to address this
concern.
4. Residual sequence extension
Based on deep sequencing, a split read should find
some overlap reads harboring the same fusion point.
If a fusion is only expressed in a single read, it
cannot be determined if the detected fusion is actual
or an internal error of the software. Therefore, as to
a split read, the 20bp segment with the fusion point
in the middle is regarded as a contig. If the residual
sequence is less than 10bp, the 20bp segment
containing this residual sequence is regarded as the
contig. All of the non-mapped reads other than the
candidate split reads are then searched, and all reads
that have this contig are selected. A set of these
selected reads may have concordant overlap with
this split read. They would be termed reference
reads to the split read. The reference reads are then
merged together to several longer sequences. The
implying gene of the short residual sequence is
decided by these longer sequences. This step is
graphically described in Figure 3.
5. Filtering false positives
In order to reduce false positive rate of fusion
detection, a list of filters are performed on the detected
fusions in this step.
a) Reads number filter. After detecting the spanning
pairs and split reads, the results are combined, and
the reads that are less possible to be true fusion
reads are filtered out. In the two-partner fusion
transcripts reported from a split read, one should
also be the aligned transcript of its mate read. The
implying fusion points of the spanning pairs and
split reads should be concordant. In addition, the
fusions are discarded if either their supporting
spanning pairs, split reads or fusion numbers are
lower than the minimum numbers user specified.
b) Similarity filter. Some detected fusion junctions may
be reported between two paralogous genes. They
often result from misalignment due to their
homology. This homology could be quantitatively
measured by the degree of sequence match between
the two genes. The matching degree is called
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similarity. The Water output from the EMBOSS
[15] pipeline is used to calculate similarity between
every pair of reported partner isoforms. The fusion
is discarded if similarity is more than 50%.
c) Distribution filter. This filter is designed based on the
hypothesis that the distributions of the positions of
the reads involved in one transcript are similar. Firstly,
a large number of “real” transcripts are randomly
selected, which have reads of both ends mapped to
transcriptome. The positions of the supporting reads
for these transcripts are collected and merged as
“background positions”. Secondly, the distributions
similarity is estimated between the positions of the
supporting reads for each of these transcript and the
“background positions” using Kolmogorov–Smirnov
(K-S) test. A list of p-values is then obtained, and their
distribution is defined as the distribution of p-values
(density function of p-values). The null hypothesis is
that the p-value of K-S test between the positions of
supporting reads for a real transcript and “background
positions” obeys the distribution of p-values. In
consequence, as to each detected fusion, the positions
of the spanning pairs are recorded, and the p-value of
K-S test between each end read positions and
“background positions” is calculated. Because the two
end reads are corresponding to two fused transcripts,
according to the null hypothesis, both the two p-
values should obey the distribution of p-values. If
either p-value falls to the significantly low level in the
p-value distribution (significant level is 0.025), the
corresponding fusion is discarded.
Phase III. Chimerical transcripts quantification
In addition to the filters above, the identification accuracy
of FusionQ is further improved by quantifying the abun-
dance of chimerical transcripts. Generally speaking, highly
expressed gene fusions are more important than those
under a low expression levels. Most tools use the number
of reads supporting the fusion junction to determine the
expression of this fusion. However, this number only re-
flects the expression level of the short region around the
fusion point. Some chimerical transcripts with higher ex-
pression levels may have many reads, but the reads do not
contain the fusion points, resulting in low supporting read
counts. In addition, due to the complexity of the transcrip-
tome, some reads may be mapped to several genes. Simply
treating them as the supporting reads of certain fusion
genes may cause misalignment and mistakenly increase
their supporting reads counts. In order to provide more
reliable expression levels for gene fusions, the quantifica-
tions should be based on the whole chimerical transcript.
Here, the framework of RSEM (RNA-Seq by Expectation
Maximization) for chimerical transcripts quantification
can be used by adding a L1 norm constraint to the num-
ber of expressed fusion transcripts.
The chimerical transcript set is denoted as Θ ¼ θif gMi¼1.
All of the paired-end reads are denoted as X. The goal is
to determine the abundances of ⌢Θ that can maximize
the sampling likelihood of X. For one transcript i, it has a
subset of supporting reads ∏ixn aligned to it. The paired-
end reads xn xn∈Π ixn
 
may come from multiple fragments
Πxn . The probability of the xn takes the j
th fragment of Πxn
is P Π jxn
 
. For each paired-end read xn, the probability of
one fragment coming from i is θi. θi is normalized by P
Π jxn
 
as well as the length of transcript li. As to a paired-
end read xn, the two ends are xαn and x
β
n, with the insert se-
quence denoted as xγn . P(xn|Znij = 1) is the probability to
get observation xn from this fragment, where the hidden
indicator random variable Znij = 1 means the alignment of
jth read Πxn aligns to transcript i. Then, taking all reads
and all possible fragments of each read together, we aim to
find Ψ that maximizes the likelihood of the sampling of
the paired-end reads in X. This likelihood is
PðXjΘÞ ¼
YN
n¼1
XM
i¼1
X
πjxn∈∏
i
xn
θi
li
P πjxn
 
P xn Znij ¼ 1Þ

Where
P xn Znij ¼ 1Þ ¼ P xαn Znij ¼ 1Þ⋅P xβn Znij ¼ 1Þ⋅Pd xγn
 
⋅P ψð Þ
Pd xγn
 
follows the empirical normal distribution of the
mate-pair distance. The probability of the sequenced end
Figure 3 Residual sequence extension step.
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reads taking the j-th element of ∏xn , P x
α
n Znij ¼ 1Þ
 and P
xβn Znij ¼ 1Þ
 , should be related with their sequence simi-
larities to the reference genome and their base call quality
score [16]. P(ψ) is the probability of the junction crossed
by one alignment of paired-end reads which can be calcu-
lated from the observed reads.
The Expectation-Maximization (EM) algorithm is then
applied to maximize the log likelihood of P(X|Θ). The key
of the EM algorithm is the expected value of the complete
data log likelihood function, given current values for the
parameters. The complete data log likelihood with
group sparsity constraints is written as logPðX;ZjΘÞ ¼
X
n;i
X
πjxn∈∏
i
xn
θi
li
log θili P π
j
xn
 
PðxnjZnij ¼ 1
h 
−_
XK
k¼1
αk jjΦk 1jj
where Φk are the abundance of transcripts with detected
junctions or fusions.
The Q function of the EM algorithm is QðΘjΘ tð ÞÞ ¼
EZjx;Θ tð Þ ½ logPðx; zjΘÞ¼
X
n;i;j
EZjx;Θ tð Þ Znij
 
log
	
θi
li
PðxnjZnij ¼ 1Þ


−
λ
X
k∈F
log θkj j.
During E-step, we calculate the expected values of the
Znij variables,
EZjx;Θ tð Þ Znij
  ¼ PðZnij ¼ 1jx;Θ tð ÞÞ
¼ ðθ
tð Þ
i =liÞPðxnjZnij ¼ 1Þ
∑i0 ;j0 ðθ tð Þi0 =li0 ÞPðxnjZni0 j0 ¼ 1Þ
In the M-step, we maximize the likelihood of Q and esti-
mate
⌢
Θ by the Lagrange multiplier method.
Based on this method, reads are mapped to the opti-
mized positions. The corresponding expression levels of
the detected fusions are then more reliable. Some of
these fusions may have expression levels approximate to
zero. That would indicate that their supporting reads are
the results of misalignment. These fusions are likely to
be artificial and could be disregarded. In this way, the fu-
sion identification accuracy is further improved.
Results
In this section, the performance of FusionQ was tested
on simulated data and cancer cell line data. Two fusion
detection tools, “deFuse”[6] and “TopHat-Fusion” [8]
were adopted for comparison.
Comparison on simulated datasets
Fifty simulated paired-end RNA-Seq datasets were gener-
ated using “Eric the Simulator” [12]. Each dataset was com-
posed of two millions “background” reads and a set of
“broken exons” (BE) fusion reads. The “background” reads
were the randomly selected ones from a published RNA-Seq
dataset of the untreated human pulmonary microvascular
endothelial cells [17]. The average length of the original
cDNA fragments was ~164bp and standard deviation was
~48. No fusion should exist in these background reads. The
BE fusion reads were generated from the 5’- and 3’- end of
50 simulated BE chimerical transcripts using wgsim (http://
github.com/lh3/wgsim) (with –d 164 –r 0.0001 –R −0.001
–s 48). Broken exon (BE) means that the fusion breakpoints
are randomly chosen without knowledge of known splicing
sites of fused genes, in which case, the breakpoints may
exist on exons. The coverage levels of the 50 simulated chi-
merical transcripts were from ranged 1 to 50. These fused
transcript partners were the randomly selected ones from
Ensemble Transcriptome database version 65. The read
length was 50bp.
Next, the three tools, FusionQ, deFuse, and TopHat-
Fusion, were performed on these 50 simulated datasets
using the same computational sources provided by the
Stampede server of “Texas advanced computing center”.
The number of threads was set as 16 as to all these three
tools. We compared detection sensitivity and specificity
of the three tools. Sensitivity is defined as the number of
true fusions detected divided by total number of true fu-
sions (50), while specificity is defined as the number of
true fusions detected divided by number of all fusions
detected. The statistics were shown in Table 1.
Besides, ROC curves were drawn based on 50-quantiles.
Firstly, the results of FusionQ, deFuse, and TopHat-Fusion
were sorted in ascending order by fusion expression
levels, estimated probabilities, and number of fusion
reads, respectively. Then, the ROC curves were plotted
with each point representing a pair of true positive rate
(TPR) and false positive rate (FPR) when only the last
kth 50-quantile results were considered. TPR and FPR
were defined as follows: as to the last kth 50-quantile,
TPR ¼ TPTPþFN and FPR ¼ FPFPþTN,
where TP and FP were the number of true and false
fusions in the last kth 50-quantile results, and TN and
FN were the number of true and false fusions in the rest
of the results.
Table 1 Performance comparison among FusionQ, deFuse
and TopHat-Fusion based on simulated data sets
Method Total
fusion No.
True
fusion No.
Specificity Sensitivity Time/
h
FusionQ 63 40 63.5% 80% 4.5
deFuse 62 37 60% 74% 3.4
TopHat-
Fusion
32 26 81% 52% 0.67
Specificity: Number of true fusions detected divided by number of all
detect fusions.
Sensitivity: Number of true fusions detected divided by total number of true
fusions (50).
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According to Table 1 and Figure 4, TopHat-Fusion cost
the least time. However, it had the lowest detection sensitiv-
ity, with only 52% true fusions detected. Although FusionQ
cost more time for computation, it outperformed the other
two programs, and excelled deFuse in both sensitivity and
specificity. The time-consuming step of FusionQ is the
transcript expression estimation. However, it is a unique
function that FusionQ has but the other two tools do not.
It can estimate the fusion transcript expression levels and
largely reduces the false positive rate. As to these 50 simu-
lated data sets, after the first three filters described in
Method Section was performed, around 65% of the rest
false fusions were excluded by means of expression filters.
True fusions were seldom filtered out.
In addition, we estimated how the read coverage af-
fected the detection ability. Among the 50 simulated
data sets, each contained fusions with coverage from 1
to 50. As to the fusion transcript of each coverage level,
we counted the number of times that the tools could de-
tect it among the 50 data sets. Hence, we obtained the
detection rates of the three tools as to each coverage
transcript. The relations between the detection rates to
chimerical transcript coverage of the three tools were
shown in Figure 5.
As shown in Figure 5, FusionQ and deFuse showed
greater detection ability than Tophat-Fusion. FusionQ
was better than deFuse when read coverage was low.
Comparison on cancer cell line datasets
In the following, FusionQ was tested on published paired-
end RNA-Seq data from four breast cancer cell lines
(BT474, SKBR3, KPL4, and MCF7). These cell lines are
known to contain 27 gene fusions [18]. Data could be
obtained from the NCBI Sequence Read Archive [SRA:
SRP003186, http://trace.ddbj.nig.ac.jp/DRASearch/study?
acc=SRP003186]. The control group of this dataset was
also employed. It was the RNA-Seq data from normal tis-
sue, which should have no gene fusions. A parallel compu-
tation was incorporated into the program to increase
detection speed. As the dataset may contain many dupli-
cate reads resulting from the PCR, quality control on
reads level was performed to remove them. This filtered
out the unnecessary reads and reduced the computational
time. This method may reduce the reads coverage level,
which could test our program on low coverage level con-
ditions. Table 2 lists the description of these datasets both
before and after quality control.
When running FusionQ, both the fusion partners were
restricted to having at least 5bp involved in one split read.
In addition, the detected split reads could have10bp seg-
ments around the fusion points having no mapping posi-
tions in the transcriptome. All of the reported fusions
should have spanning pairs and split reads. Furthermore,
the mismatches between the reads and transcriptome were
restricted to less than three, while those between the seeds
and transcriptome to less than one. Because quality con-
trol was performed on the data from the breast cancer cell
lines and normal tissues, the detected fusion numbers
should be smaller. As a result, fusions that have more than
one split read and one spanning pair were reported, but
the total numbers of supporting reads are more than
three. Additionally, UCSC hg19 was used as the reference
human genome [19], and the reference transcriptome was
constructed using “TopHat” [20], then Cufflinks (v 1.3.0).
When using Cufflinks, a reference annotation for UCSC
hg19 (.gtf) was supplied to guide the assembly steps.
Besides FusionQ, two fusion detection tools (deFuse” and
“TopHat-Fusion) were applied to datasets after performing
Figure 4 ROC curves obtained from the results of FusionQ,
deFuse and TopHat-Fusion.
Figure 5 The detection ability to different coverage levels of
FusionQ, deFuse, and TopHat-Fusion.
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quality controls, and their performances were compared
with FusionQ. The results of TopHat-Fusion were re-
stricted to containing more than one split read, one span-
ning pair, and more than three supporting fusion reads,
which is the same as FusionQ. deFuse requires at least five
spanning pairs to nominate a gene fusion to the classifier.
In consequence, deFuse was restricted to having at least
one split read and five spanning pairs. Other parameters
of these two tools are by default. After computation,
the detected fusions by these three tools were listed
in Additional files 1: Table S1, Additional file 2: Table S2,
Additional file 3: Table S3. Table 3 provides a summary of
the detection results.
In total, TopHat-Fusion reported 111 fusions and
FusionQ reported 298 fusions, while deFuse reported 1932
fusions, as shown in Table 3. This demonstrated that
FusionQ reported less false-positive fusions than those
reported by deFuse. Among the 27 documented fusions,
FusionQ detected 22 of them, while deFuse and TopHat-
Fusion detected 20 and 16 fusions, respectively. This is
quite different from the results on data before quality con-
trol. While the quality control will significantly reduce the
number of false-positives, its performing will result in a
corresponding decrease in reads coverage, TopHat-Fusion
showed unstable performance, and could not predict some
very low coverage reads. FusionQ showed more sensitivity
in this occasion. The detection results of the 27 reported
fusions by the three tools are presented in Table 4.
As shown in Table 4, FusionQ includes gene fusion
WDR67-ZNF704, which is missed by the other two
methods. This demonstrates that FusionQ has the highest
sensitivity. The number of reads detected by FusionQ and
TopHat-Fusion are comparable, although FusionQ had
much higher sensitivity than TopHat-Fusion. deFuse
seems to detect a higher number of fusion reads than that
done by FusionQ and TopHat-Fusion. This is probably be-
cause FusionQ and TopHat-Fusion use Bowtie mapping,
of which the mapping criteria is more strict, whereas de-
Fuse uses dynamic programming to decide the sequence
alignment, of which the criteria is loose, and false fusions
may not be completely ruled out. In summary, FusionQ
could report more fusions among all reported when the
reads coverage is low. This demonstrated the advantage of
FusionQ in detection sensitivity. Meanwhile, the total
number of fusions detected by FusionQ is much less than
that of deFuse, which means that FusionQ could report fu-
sions with less false positives than deFuse.
Fusion structure construction
Here, the BCAS4-BCAS5 gene fusion in the MCF7 cell
line is used as an example to demonstrate fusion structure
construction. This fusion results from the first exon of
BCAS4 fused to exon 1 of BCAS3, as shown in Figure 6(a).
Only a few fusion reads used in this example. The fusion
points are the bars of each read, separating each read into
two segments. Using the “residual sequence extension”
algorithm, the two segments of each read can be extended
into longer ones. The extended segments are uniquely
mapped to BCAS4 and BCAS3, respectively. Moreover,
Figure 6(b) describes all of the possible chemical trans-
cripts of BCAS4-BCAS3.
Abundance quantification by FusionQ
The proposed scoring function in Phase II is based on
the numbers and distributions of supporting reads. Fu-
sions with higher scores have better features around the
fusion point, and are more likely to be true fusions. The
scoring function judges the fusions from a local view.
Furthermore, to profile the fusions from a global view,
the abundance of the detected fusions is quantified using
the method described in Phase III. This method could
determine the optimized mapping positions of each read,
as well as the average expression level of all transcripts,
including the chimerical transcripts. Fusions with very
low expression levels could be disregarded after the ana-
lysis. This step improves the accuracy of the fusion
detection.
Here, the detection results based on the data from the
KPL4 cell line are presented. In total, 15 fusion genes
were detected, including 22 fusion transcripts. The rank-
ing score and expression level of every detected fusion
are shown in Table 5.
As shown in Table 5, all of the three reported fusions
in bold have higher expression levels, although one of
them, NUP214-NOTCH1, does not have many
supporting reads. This confirms that the expression esti-
mation by the EM algorithm is significantly more reli-
able than read counts. In addition, some fusions with
Table 2 Paired-end RNA-Seq data in the test dataset
Cancer
type
Sample
names
Fragment
lengths
Read
length
Read
numbers
before QC
Read
numbers
after QC
Breast cancer BT474 100, 200 50 21,423,697 9,416,283
SKBR3 100, 200 50 18,140,246 7,190,185
KPL4 100 50 6,796,443 2,616,395
MCF7 100 50 8,409,785 4,223,773
Normal tissue Normal 100 50 4,564,298 2,701,076
Table 3 Summary of the detected fusions by the three tools
FusionQ deFuse TopHat-Fusion
Total number of fusions 298 1932 111
No. of detected fusions that are
reported/ No. of documented
fusions
81%
(22/27)
74%
(20/27)
59%
(16/27)
Comparison of the fusion number by FusionQ, deFuse, and TopHat-Fusion.
Empty cells denote a failure of the tool to report a particular fusion.
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Table 4 Fusion detection performance comparison based on cancer cell line data sets
Library Name Fusion genes deFuse TopHat-Fusion FusionQ
split reads spanning reads split reads spanning reads split reads spanning reads
SKBR3 TATDN1-GSDMB 67 51 94 27 144 19
SKBR3 RARA-PKIA 7 12 6 7 4 11
SKBR3 ANKHD1-PCDH1 7 14 4 7 6 8
SKBR3 CCDC85C-SETD3 4 6 3 5
SKBR3 SUMF1-LRRFIP2 9 16 3 9
SKBR3 CSE1L-ENSG00000236127 7 19
SKBR3 WDR67-ZNF704 2 1
SKBR3 CYTH1-EIF3H 5 27 7 22
SKBR3 DHX35-ITCH 4 5 4 1
SKBR3 NFS1-PREX1
BT474 ACACA-STAC2 20 20 14 44 8 27
BT474 RPS6KB1-SNF8 28 31 24 32 9 11
BT474 VAPB-IKZF3 13 31 26 27 8 17
BT474 ZMYND8-CEP250 7 16 10 11 8 17
BT474 RAB22A-MYO9B 9 5 10 1 3 4
BT474 SKA2-MYO19 5 6 10 5 3 3
BT474 DIDO1-KIAA0406 1 3
BT474 STARD3-DOK5 3 3 1 3
BT474 LAMP1-MCF2L
BT474 GLB1-CMTM7 2 6 1 3
BT474 CPNE1-PI3
MCF7 BCAS4-BCAS3 67 77 54 39 14 40
MCF7 ARFGEF2-SULF2 25 24 5 8 13 11
MCF7 RPS6KB1-TMEM49 6 8 3 3 2 1
KPL4 BSG-NFIX 23 18 4 11 3 13
KPL4 PPP1R12A-SEPT10 6 8 5 2
KPL4 NOTCH1-NUP214 2 6 3 3
Figure 6 Structure of BCS4-BCAS3. The left figure shows the construction process. The reads in black are the original reads. The bars of
each read are the fusion points. Using our algorithm, the reads are merged together, with the green one involved in BCAS4, and the red one
involved in BCAS3. The fusion has two different chemical transcripts, which are shown in the right figure.
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more supporting reads could have relatively low expres-
sion, such as BSG-NFIC. The supporting reads of these
fusions may contain some misalignments. Furthermore,
the misalignment could cause artificial fusion junctions.
However, after abundance quantification, the expression
levels of these artificial fusions are approximate zeros.
As a result, this quantification could further improve the
accuracy of fusion identification.
Among the results listed in Table 5, the three reported fu-
sions along with four other fusions (ACIN1-C14ORF,
BCL9L-CUFF.3497, BRWD1-LOC100132288, and WNT5A-
CUFF.12313) have higher expression levels. These fusions
are mostly likely to be true fusions based on the
FusionQ program. Besides, the gene partners with pre-
fix “CUFF” are novel genes predicted by Cufflinks. The
three fusions, BSG-NFIC, SGK269-KIAA1328, and
C9ORF129-CUFF.14016, have relatively lower expres-
sions. Their scores are relatively low. These fusion
genes are judged as true fusions by FusionQ. As to the
three fusions, LRRIQ1-SEC14L1, ASTN2-CUFF.8591,
and ASTN2-CUFF.8591, the expression levels are ap-
proximate zeros. This means that these fusion junctions
are artificial, and could be disregarded. In summary, the
scores and expression values could help to select the
potential fusions for further validation.
Discussion and Conclusion
In this study, we developed a novel tool, FusionQ, to de-
tect gene fusions, construct the chimerical transcripts
structures, and estimate their expressions. FusionQ uses a
splice algorithm for fusion detection. To determine the
position of short segments in the transcriptome, we pro-
posed a new approach using a residual sequence extension
algorithm. The short segments of the reads are extended
by aggregating their overlapping reads. This approach
makes the prediction more precise. We also incorporated
filters to the detected results, which reduced the false-
positive rate. Moreover, instead of describing a fusion ex-
pression level using the number of supporting reads, we
used sparse optimization to quantify the abundance of a
fusion transcript. Results show that this method is more re-
liable than using the supporting read count. The abundance
quantification also further improves the identification ac-
curacy of our approach. We compared FusionQ with two
current fusion detection tools, deFuse and TopHat-Fusion
using simulated data and cancer cell line data. FusionQ
showed better detection capacity than TopHat-Fusion in
low coverage situations. Its performance was comparable
with deFuse, but the total number of fusions reported by
FusionQ is much lower than that by deFuse, as shown in
Table 3. Hence, FusionQ could report fusions with a lower
false-positive rate. As abnormal chromosome transloca-
tion is one of the important pathogenic factors in cancer
development, our FusionQ approach will facilitate accur-
ate detection of gene fusions for disease diagnosis and
identification of potential targets for gene therapy.
Availability and requirements
Project name: FusionQ: a novel approach for detection and
quantification of gene fusions from paired-end RNA-Seq
Project home page: http://www.wakehealth.edu/CTSB/
Software/Software.htm
Operating system: 64-bit Linux (The program has
been tested on Ubuntu, Debian, and Centos)
Programming language: C++, Perl and R
Other requirements: Boost C++ libraries,1.42.0 and
above.
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Additional file 1: Table S1. Fusion Reports from FusionQ.
Additional file 2: Table S2. Fusion Reports from Tophat-Fusion.
Additional file 3: Table S3. Fusion Reports from deFuse.
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